Fitbit, Inc. (FIT)
(Delayed Data from NYSE)
$5.09 USD
+0.13 (2.62%)
Updated May 3, 2019 04:03 PM ET
After-Market: $5.09 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$5.09 USD
+0.13 (2.62%)
Updated May 3, 2019 04:03 PM ET
After-Market: $5.09 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Earnings Preview: Fitbit (FIT) Q3 Earnings Expected to Decline
by Zacks Equity Research
Fitbit (FIT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Does Google Want to Buy Fitbit?
by Madeleine Johnson
Google's parent company Alphabet (GOOGL) has reportedly made an offer to buy Fitbit (FIT), sending shares of the wearables maker
Garmin (GRMN) Expands in Fitness Segment With Garmin Swim 2
by Zacks Equity Research
Garmin (GRMN) has been making significant investments in the fitness segment, which in turn helps it to develop a solid product line.
3 Cloud Computing Stocks for Tech Investors to Buy in the Fourth Quarter
by Benjamin Rains
Check out these three cloud-focused SaaS stocks we found using our Zacks Stock Screener for tech investors to consider buying in the fourth quarter of 2019...
DexCom's (DXCM) New G6 Pro CGM System Gets FDA Approval
by Zacks Equity Research
FDA approval for DexCom's (DXCM) G6 Pro boosts the company's broad product spectrum.
Why I Like Garmin (GRMN) Stock
by Sejuti Banerjea
Garmin shares have appreciated nicely over the past year but there's reason to believe that there's further upside.
Fitbit (FIT) Collaborates With FibriCheck to Reduce Stroke
by Zacks Equity Research
Fitbit (FIT) partners with FibriCheck in a bid to expand its share in the healthcare market.
Implied Volatility Surging for Fitbit (FIT) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Fitbit (FIT) stock based on the movements in the options market lately.
3 Dividend-Paying Tech Stocks for Income Investors to Buy Right Now
by Benjamin Rains
We searched for strong tech companies that also pay a dividend, utilizing our Zacks Stock Screener. These three tech stocks should remain attractive to investors even during a potential market downturn...
Apple Roundup: Products, Security Issues, Analyst Opinion & Trillion-Dollar Valuation
by Sejuti Banerjea
Apple's new products, Goldman's reservations about the stock, iPhone security issues and its trillion-dollar valuation are the highlights of this roundup.
Apple's Watch 5 Headway in Healthcare Makes Others Take Note
by Shilpa Mete
Healthcare battle is heating up with the growing proliferation of fitness trackers being offered by Apple (AAPL), Fitbit, Garmin and others.
Tech Taking Personal Healthcare by Storm: Stocks in Focus
by Zacks Equity Research
Personal healthcare market is booming on expanding initiatives by tech giants like Apple (AAPL), Fitbit (FIT) and Alphabet (GOOGL), to name a few.
Electronics-Measuring Instruments Industry Outlook Looks Dim
by Shilpa Mete
Electronics - Measuring Instruments industry is hurt by U.S.-China trade tensions and rapidly-changing technologies despite its strong exposure to major sectors.
The Zacks Analyst Blog Highlights: Amazon, Apple, Fitbit and Alphabet
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Amazon, Apple, Fitbit and Alphabet
Apple Roundup: Tariffs, FAA, Russia, Music, App Store, Security
by Sejuti Banerjea
Good news about tariffs on iPhone, iPads, Macs, etc not kicking in until Dec 15 more than offset things like the FAA restricting some risky devices on flights, an antitrust probe in Russia and other.
Fitbit (FIT) Q2 Loss Narrower Than Estimated, Revenues Beat
by Zacks Equity Research
Fitbit (FIT) reports strong second-quarter revenues on the back of strength in trackers.
Fitbit (FIT) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Fitbit (FIT) delivered earnings and revenue surprises of 22.22% and 0.34%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Will Fitbit (FIT) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Fitbit (FIT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Trimble Mapping Solutions Unit Gains Momentum with 3Gtms Deal
by Zacks Equity Research
Trimble (TRMB) wins a partnership from 3Gtms for its commercial routing solutions, which in turn expands its clientele.
Jabil (JBL) Q3 Earnings Beat, Revenues Up on EMS Growth
by Zacks Equity Research
Jabil's (JBL) third-quarter fiscal 2019 results benefit from strong growth in the EMS segment.
Altair Engineering, Netgear, Fitbit, Microsoft and DexCom highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Altair Engineering, Netgear, Fitbit, Microsoft and DexCom highlighted as Zacks Bull and Bear of the Day
3 "Internet of Things" Stocks to Buy Right Now
by Benjamin Rains
Today we've highlighted three stocks with a Zacks Rank #2 (Buy) or better that could be poised for further IoT-based growth soon.
Fitbit (FIT) Down 5.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Fitbit (FIT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Alphabet (GOOGL) Deepens Focus on Cardio Diseases with Verve
by Zacks Equity Research
Alphabet (GOOGL) focuses on reducing risks of heart diseases by working on the development of one-time injectable treatment in collaboration with Verve Therapeutics.
Ford, American Airlines, Qualcomm and Fitbit as Zacks Bull and Bear of the Day
by Zacks Equity Research
Ford, American Airlines, Qualcomm and Fitbit as Zacks Bull and Bear of the Day